Close Menu

NEW YORK – Quest Diagnostics confirmed it has been cleared in US District Court for the Central District of California Western Division of misappropriating trade secrets from Cedars-Sinai Medical Center in developing a serological test for irritable bowel syndrome.

A jury last week determined that Quest did not steal trade secrets from Cedars-Sinai or breach its contract with the hospital when it developed an IBS test similar to one developed by Cedars-Sinai researchers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.